Skip to main content

Table 1 Maternal, pregnancy, and disease characteristics according to time of infection and disease activity

From: Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study

 

Infection at the First trimester

(N = 38)

Infection at the Second trimester

(N = 65)

Infection at the Third trimester

(N = 57)

No active disease

(N = 158)

Active disease at birth (N = 31)

Overall

(N = 189)

Maternal age (years)

33.0 [30.3, 37.0]

34.0 [30.0, 37.0]

31.0 [28.0, 36.0]

33.0 [29.0, 37.0]

33.0 [28.5, 37.0]

33.0 [29.0, 37.0]

Height (cm)

165 [159, 170]

162 [159, 168]

161 [156, 168]

163 [158, 169]

161 [156, 166]

163 [158, 168]

Weight (kg)

65.0 [56.3, 74.8]

69.0 [58.0, 76.0]

62.5 [54.0, 70.3]

65.0 [56.5, 74.0]

60.0 [54.4, 74.0]

64.5 [56.0, 74.0]

Missing

0 (0%)

0 (0%)

1 (1.8%)

1 (0.6%)

0 (0%)

1 (0.5%)

Body mass index (kg/m2)

24.2 [21.5, 27.5]

24.9 [21.5, 28.7]

23.4 [21.7, 25.8]

24.1 [21.5, 27.6]

24.7 [21.0, 28.7]

24.2 [21.5, 28.0]

COVID-19 Diagnosis with

 Antigens

9 (23.7%)

13 (20.0%)

7 (12.3%)

29 (18.4%)

3 (9.68%)

32 (16.9%)

 RRT-PCR

20 (52.6%)

38 (58.5%)

38 (66.7%)

94 (59.5%)

26 (83.9%)

120 (63.5%)

 Serology

9 (23.7%)

14 (21.5%)

12 (21.1%)

35 (22.2%)

2 (6.45%)

37 (19.6%)

Gestational age at diagnosis of COVID-19 (days)

65.5 [50.5, 82.8]

162 [132, 184]

240 [226, 254]

176 [105, 226]

268 [265, 280]

195 [115, 248]

COVID-19 symptoms

 Asymptomatic

6 (15.8%)

8 (12.3%)

17 (29.8%)

30 (19.0%)

17 (54.8%)

47 (24.9%)

 Mild

31 (81.6%)

50 (76.9%)

33 (57.9%)

113 (71.5%)

12 (38.7%)

125 (66.1%)

 Pneumonia

1 (2.63%)

7 (10.8%)

7 (12.3%)

15 (9.49%)

2 (6.45%)

17 (8.99%)

Gestational age at birth (days)

279 [270, 284]

277 [272, 283]

278 [274, 283]

278 [273, 284]

275 [268, 286]

278 [272, 284]

  1. Results are presented as median (interquartile range) or as n (%) as appropriate